Prostate cancer
Open
Phase 3
This trial is comparing stereotactic body radiotherapy to the prostate with stereotactic body radiotherapy to the prostate and lymph nodes in the .
It is open to people with prostate cancer that has a high risk of the cancer coming back.
Recruitment start: 5 September 2022
Recruitment end: 30 September 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nicholas Van As
Institute of Cancer Research (ICR)
National Institute for Health Research Clinical Research Network (NIHR CRN)
Prostate Cancer UK
The Radiotherapy Trials Quality Assurance (RTTQA) Group
Last reviewed: 27 February 2025
CRUK internal database number: 19920